TSHA Competitors & Alternatives
Compare Taysha Gene Therapies Inc with similar stocks in the same industry
Biotechnology
TSHA
Main Stock$5.45
Tradestie Score
54
Market Cap
$867.49M
Revenue Growth
1.7%
Analyst Upside
+117.8%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$8.38
|
$1.92B | - | 49 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$132.18
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$56.97
|
$1.90B | 348.8 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$34.35
|
$1.84B | - | 55 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.37
|
$1.81B | - | 55 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$4.16
|
$1.78B | - | 51 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$16.54
|
$1.78B | - | 47 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.10
|
$1.74B | - | 58 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.22
|
$1.68B | - | 55 | Compare |
|
MNKD
Mannkind Corporation
|
$2.99
|
$1.65B | - | 56 | Compare |
More TSHA Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry